Digital Features
The American Journal of Cardiovascular Drugs is able to host a range of digital features, with a number of options available to authors.
Promoting rational therapy within the discipline of cardiology, the American Journal of Cardiovascular Drugs covers all aspects of the treatment of cardiovascular disorders, particularly the place in therapy of newer and established agents.
Via a program of reviews and original clinical research articles, the journal addresses major issues relating to treatment of these disorders, including the pharmacology, efficacy and adverse effects of the major classes of drugs; information on newly developed drugs and drug classes; the therapeutic implications of latest research into the aetiology of cardiovascular disorders; and the practical management of specific clinical situations.
As a hybrid journal, the American Journal of Cardiovascular Drugs does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information).
The American Journal of Cardiovascular Drugs offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information).
The American Journal of Cardiovascular Drugs is able to host a range of digital features, with a number of options available to authors.